Global Life Science Ventures (GLSV) is a leading, independent venture capital fund focusing exclusively on the life sciences. GLSV is dedicated to supporting early-stage groups, originating from universities, scientific institutions or industry. The fund may also invest in selected later stage companies, including buy-outs. For this purpose, GLSV provides finance, advice and access to expertise and networks. The group currently advises and manages funds totalling more than € 200 million. With offices in Germany and Switzerland, GLSV acts as one team with a global perspective.
12th Annual Biotech in Europe Investor Forum
October 01-02, 2012, Zurich, Switzerland
Click here for further information
GLSV Annual Investors Meeting
June 28, 2012, Munich, Germany
5th Annual European Life Science CEO Forum
March 06-07, 2012, Zurich, Switzerland
Click here for further information